In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Optimizing Study Design in Real-World Evidence Generation
An Applied Clinical Trials article written by ICON’s Rob Sambrook exploring the importance of specialist epidemiology knowledge, due to their specialised focus on pharmacoepidemiological study design, to ensure robust and reliable downstream study findings.
-
Connecting With The Patient
E.B. McLindon, Senior Vice President, Site and Patient Solutions, explains how ICON is taking a different approach with its Integrated Site Network and how getting more connected with the patient and easing the burden is really making a difference to enrollment rates in this Scrip 100 article.
-
A Look at Cost Challenges of Precision Medicine & Rare Disease
Published by Pharmafocus, authored by Will Maier, Chief Scientific Officer, Head of Rare Disease Research, ICON Commercialization and Outcomes, this article explores the cost challenges presented by precision medicine in rare disease and the strategies that can be employed to overcome them.
-
An Icon" in Clinical Research"
An article published by MoneyShow featuring ICON, which discusses ICON's unmatched global reach and expertise in oncology and work with Pfizer. In addition, the article discusses the role of the CRO in overcoming challenges in clinical trials.
-
ACT NOW – Cancer Trials At The Leading Edge
A thought leadership article published by Scrip, authored by Martin Lachs, Olivier Saulin and Chris Learn, on how CROs can best support increasing demand for Adoptive Cellular Transfer (ACT) clinical trials, and what sites can expect and commit to when participating in ACT trials.
-
Icon non-executive chairman awarded RDS gold medal for outstanding leadership
An article published by The Irish Times featuring commentary from Ciarán Murray on his achievement of being awarded with the RDS gold medal for enterprise for his “outstanding professional and leadership skills”.
-
Ciarán Murray – an Icon of leadership in pharma sector
An article published by The Irish Times featuring commentary from Ciarn Murray on the growth of ICON and his career journey to achieve the RDS Gold Medal for Industry.
-
Oncology clinical trials in APAC
Although Asia Pacific (APAC) is sometimes referred to as a homogenous unit, it is a heterogeneous region, with divergent countries, languages, populations and cultures. The main pharmaceutical markets, Japan, China, South Korea, Taiwan and Australia, have different business, labor and regulatory environments, so the characteristics of clinical development also differ.
Clinical research in APAC is very well established, with high-quality research infrastructure, and some Centers of Excellence have leapfrogged the West, especially in IT and equipment. Many multinational pharmaceutical companies and CROs have been in the region for more than 20 years, so there is a great depth of experience to draw on.
In terms of the value of the pharmaceutical market, China and Japan are second and third in the world, respectively, after the US, which reflects their importance in the overall global market. In this article, we review some of the characteristics of clinical research in APAC and some of the factors affecting it, particularly in oncology.
-
Key Considerations for Disease Modifying Parkinson's Disease Trials
A thought leadership article by Peter Schueler and Haichen Yang on the key considerations for disease modifying parkinson's disease trials. This article is featured in Pharmaceutical Market Europe (PME).
-
How to use digital health in clinical trials to improve patient engagement
Read this Medical Design and Outsourcing article, written by Vicki Anastasi and Matthew McCarty, to discover how a unified patient experience, where patients can manage every aspect of their trial via a single one-touch access point (such as an integrated smart phone app), can work to optimise data collection and improve patient retention and engagement.
